Meditera Tibbi Malzeme Sanayi ve Ticaret AS (IS:MEDTR) — Market Cap & Net Worth
Market Cap & Net Worth: Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR)
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (IS:MEDTR) has a market capitalization of $63.91 Million (TL2.85 Billion) as of June 22, 2026. Listed on the IS stock exchange, this Turkey-based company holds position #20990 globally and #343 in its home market, demonstrating a 0.20% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Meditera Tibbi Malzeme Sanayi ve Ticaret AS's stock price TL30.08 by its total outstanding shares 94865725 (94.87 Million). Review total liabilities of Meditera Tibbi Malzeme Sanayi ve Ticaret to assess the company's total debt and financial obligations.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Market Cap History: 2021 to 2026
Meditera Tibbi Malzeme Sanayi ve Ticaret AS's market capitalization history from 2021 to 2026. Data shows growth from $27.23 Million to $63.91 Million (31.74% CAGR).
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Meditera Tibbi Malzeme Sanayi ve Ticaret AS's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $27.23 Million | $375.93 Million | $167.70 Million | 0.07x | 0.16x |
| 2022 | $80.73 Million | $806.04 Million | $297.05 Million | 0.10x | 0.27x |
| 2023 | $58.78 Million | $2.10 Billion | $37.35 Million | 0.03x | 1.57x |
| 2024 | $112.40 Million | $2.74 Billion | $96.11 Million | 0.04x | 1.17x |
| 2025 | $61.11 Million | $2.87 Billion | -$9.27 Million | 0.02x | N/A |
Competitor Companies of MEDTR by Market Capitalization
Companies near Meditera Tibbi Malzeme Sanayi ve Ticaret AS in the global market cap rankings as of June 22, 2026.
Key companies related to Meditera Tibbi Malzeme Sanayi ve Ticaret AS by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Historical Marketcap From 2021 to 2026
Between 2021 and today, Meditera Tibbi Malzeme Sanayi ve Ticaret AS's market cap moved from $27.23 Million to $ 63.91 Million, with a yearly change of 31.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | TL63.91 Million | +4.59% |
| 2025 | TL61.11 Million | -45.63% |
| 2024 | TL112.40 Million | +91.23% |
| 2023 | TL58.78 Million | -27.20% |
| 2022 | TL80.73 Million | +196.49% |
| 2021 | TL27.23 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of Meditera Tibbi Malzeme Sanayi ve Ticaret AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $63.91 Million USD |
| MoneyControl | $63.91 Million USD |
| MarketWatch | $63.91 Million USD |
| marketcap.company | $63.91 Million USD |
| Reuters | $63.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Meditera Tibbi Malzeme Sanayi ve Ticaret AS
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers two-way and single-line Infusion Systems; Chemotherapy Preparation and Administration Systems, such as medoconco automated drug preparation, diana semi-automatic drug dispensing, and ICU medical chemotherapy drug delivery systems; and respiratory systems products, includin… Read more